More on LEXX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.05 |
|
|||
| Open | $4.15 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.72 | ||||
| Day Low | $3.65 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 187,254 | ||||
- Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
- Lexaria Bioscience raises $5.9M through warrant exercise
- Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
- Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Lexaria receives $2.6M tax rebate from Australian R&D program
- Lexaria Receives USD$2.6 Million Tax Rebate Payment
- DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
- Form 8-K Lexaria Bioscience Corp. For: Aug 17
- Lexaria signs material transfer agreement with PegBio for GLP-1 study
- Lexaria Enters a Material Transfer Agreement With PegBio
Entities mentioned with LEXX
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- S1 | View Related Stories »
- Show More...
